Guidance Document - Certificates of Supplementary Protection (French, HTML)

View metadata and access the original French HTML file: Guidance Document - Certificates of Supplementary Protection.

Format

HTML

Access

file-only

Publisher-reported update

2023-12-02

In agreeing to apply the Canada-European Union Comprehensive Economic and Trade Agreement (CETA), Canada has committed to provide up to two years of sui generis (of its own kind) protection for new pharmaceutical products protected by an eligible patent, from the expiry of the patent. Canada has implemented this commitment by introducing Certificates of Supplementary Protection (CSPs) for medicinal ingredients, applicable for Canadian pharmaceuticals, biologics and veterinary drugs.

Access original file